Advertisement

Sarcoma of Extremities Presenting as Ulceration

  • Carlo Perisano
  • Giulio Maccauro
Chapter

Abstract

Sarcomas are relative rare malignant tumors arising from the mesenchymal tissue, which encompasses muscles, fat, bone, blood vessels, and fibrous or other supporting tissue [1]. An ulcer is a local defect or excavation of the surface of an organ or tissue characterized by a “full-thickness depth,” which implies that there are no sources for reepithelialization left in the center of the ulcer, and a “slow healing tendency” [2].

Keywords

Soft Tissue Sarcoma Malignant Bone Tumor Bone Sarcoma Venous Insufficiency Epithelioid Sarcoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Perisano C, et al. Misdiagnosis of soft tissue sarcomas of the lower limb associated with deep venous thrombosis: report of two cases and review of the literature. BMC Musculoskelet Disord. 2013;14:64.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Baker SR, et al. Epidemiology of chronic venous ulcers. Br J Surg. 1991;78:864–7.CrossRefPubMedGoogle Scholar
  3. 3.
    Ilaslan H, et al. Clinical presentation and imaging of bone and soft-tissue sarcomas. Cleve Clin J Med. 2010;77 Suppl 1:S2–7.CrossRefPubMedGoogle Scholar
  4. 4.
  5. 5.
    Simon MA, Springfield D. Surgery for Bone and Soft-Tissue Tumors. Philadelphia, PA: Lippincott-Raven; 1998. p. 198–200.Google Scholar
  6. 6.
    Burningham Z et al. The epidemiology of sarcoma. Clin Sarcoma Res. 2012. doi:  10.1186/2045-3329-2-14.
  7. 7.
    SEER*Stat Database: incidence – SEER 9 regs research Data, Nov 2010 Sub (1973–2008) < Katrina/Rita Population Adjustment > − Linked To County Attributes – Total U.S., 1969–2009 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2011, based on the November 2010 submission. Surveillance, Epidemiology, and End Results (SEER) Program (http://www.seer.cancer.gov)
  8. 8.
    Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Waldron W, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA, Edwards BK, editors. SEER cancer statistics review, 1975–2008. National Cancer Institute. Bethesda; http://seer.cancer.gov/csr/1975_2008/, based on November 2010 SEER data submission, posted to the SEER web site. 2011.
  9. 9.
    Perisano C, et al. Soft tissue metastases in lung cancer: a review of the literature. Eur Rev Med Pharmacol Sci. 2012;16(14):1908–14.PubMedGoogle Scholar
  10. 10.
    Lookingbill DP, et al. Skin involvement as the presenting sign of internal carcinoma. J Am Acad Dermatol. 1990;22:19–26.CrossRefPubMedGoogle Scholar
  11. 11.
    Ryan TJ. The epidemiology of leg ulcers. In: Westerhof W, editor. Leg Ulcers: Diagnosis and Treatment. Amsterdam: Elsevier Science Publishers BV; 1993.Google Scholar
  12. 12.
    Dowsett C. Malignant fungating wounds: assessment and management. Br J Nurs. 2002;7:394–400.CrossRefGoogle Scholar
  13. 13.
    Clark J. Metronidazole gel in managing malodorous fungating wounds. Br J Nurs. 2002;11(6 Suppl):S54e–60.CrossRefGoogle Scholar
  14. 14.
    Probst S, et al. Malignant fungating wounds: a survey of nurses’ clinical practice in Switzerland. Eur J Oncol Nurs. 2009;13:295–8.CrossRefPubMedGoogle Scholar
  15. 15.
    Haisfield-Wolfe ME, Rund C. Malignant cutaneous wounds: a management protocol. Ostomy Wound Manage. 1997;43(1):56–60.PubMedGoogle Scholar
  16. 16.
    Mekkes JR, et al. Causes, investigation and treatment of leg ulceration. Br J Dermatol. 2003;148:388–401.CrossRefPubMedGoogle Scholar
  17. 17.
    Khan AF, et al. Prevalence and presentation of chronic venous disease in Pakistan: a multicentre study. Phlebology. 2013. doi: 10.1258/phleb.2012.011122.PubMedGoogle Scholar
  18. 18.
    Shmookler B et al. Bone and soft-tissue sarcomas: epidemiology, radiology, pathology and fundamentals of surgical treatment. Musculoskeletal cancer surgery. 2001. p. 3–35. doi:  10.1007/0-306-48407-2_1
  19. 19.
    Schwartz RA. Cutaneous metastatic disease. J Am Acad Dermatol. 1995;33:161–82.CrossRefPubMedGoogle Scholar
  20. 20.
    Collier M. The assessment of patients with malignant fungating wounds – a holistic approach: part 1. Nurs Times. 1997;93(suppl):1–4.Google Scholar
  21. 21.
    Grocott P, Cowley S. The palliative management of fungating malignant wounds – generalising from multiple case study data using a system of reasoning. Int J Nurs Stud. 2001;38:533–45.CrossRefPubMedGoogle Scholar
  22. 22.
    Naylor W. Assessment and management of pain in fungating wounds. Br J Nurs. 2001;10 Suppl 22:S33–6.CrossRefPubMedGoogle Scholar
  23. 23.
    Eary JF, Conrad EU. Imaging in sarcoma. J Nucl Med. 2011. doi: 10.2967/jnumed.111.092999.PubMedCentralGoogle Scholar
  24. 24.
    White LM, Buckwalter KA. Technical considerations: CT and MR imaging in the postoperative orthopedic patient. Semin Musculoskelet Radiol. 2002;6:5–17.CrossRefPubMedGoogle Scholar
  25. 25.
    Wu JS, Hochman MG. Soft-tissue tumors and tumorlike lesions: a systematic imaging approach. Radiology. 2009;253:297–316.CrossRefPubMedGoogle Scholar
  26. 26.
    Chan WP. Magnetic resonance imaging of soft-tissue tumors of the extremities: a practical approach. World J Radiol. 2013;5(12):455–9.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Blodgett TM, et al. Issues, controversies, and clinical utility of combined PET/CT imaging: what is the interpreting physician facing? AJR Am J Roentgenol. 2005;184 Suppl 5:S138–45.CrossRefPubMedGoogle Scholar
  28. 28.
    Grocott P. The management of fungating wounds. J Wound Care. 1999;8:232–4.CrossRefPubMedGoogle Scholar
  29. 29.
    Maida V. Wound management in patients with advanced illness. Curr Opin Support Palliative Care. 2013. doi: 10.1097/SPC0b013e32835c48e5.Google Scholar
  30. 30.
    Ferris FD, et al. Palliative wound care: managing chronic wounds across life’s continuum: a consensus statement from the International Palliative Wound Care Initiative. J Palliat Med. 2007;10:37–9.CrossRefPubMedGoogle Scholar
  31. 31.
    Meaume S, et al. Neoplastic wounds and degenerescence. J Tissue Viability. 2013. doi: 10.1016/j.jtv.2013.07.001.PubMedGoogle Scholar
  32. 32.
    Wafa H, Grimer RJ. Surgical options and outcomes in bone sarcoma. Expert Rev Anticancer Ther. 2006;6(2):239–48.CrossRefPubMedGoogle Scholar
  33. 33.
    Gaston CL, et al. Is limb salvage surgery safe for bone sarcomas identified after a previous surgical procedure? Bone Joint J. 2014;96-B(5):665–72.CrossRefPubMedGoogle Scholar
  34. 34.
    Papagelopoulos PJ, et al. Current concepts for management of soft tissue sarcomas of the extremities. J Surg Orthop Adv. 2008;17:204–15.PubMedGoogle Scholar
  35. 35.
    Daigeler A, et al. Proximal major limb amputations: a retrospective analysis of 45 oncological cases. World J Surg Oncol. 2009;7:15.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Dion N, Sim FH. The use of allografts in musculoskeletal oncology. Instr Course Lect. 2002;51:499–506.PubMedGoogle Scholar
  37. 37.
    Capanna R, et al. A new technique for reconstructions of large metadiaphyseal bone defects: a combined graft (allograft shell plus vascularized fibula). Orthop Traumatol. 1993;2:159–77.CrossRefGoogle Scholar
  38. 38.
    Scoccianti G, et al. The use of osteo-articular allografts for reconstruction after resection of the distal radius for tumour. J Bone Joint Surg Br. 2010;92(12):1690–4.CrossRefPubMedGoogle Scholar
  39. 39.
    Chang DW, Robb GL. Recent advances in reconstructive surgery for soft-tissue sarcomas. Curr Oncol Rep. 2000;2:495–501.CrossRefPubMedGoogle Scholar
  40. 40.
    Chen CM, et al. Reconstruction of extremity long bone defects after sarcoma resection with vascularized fibula flaps: a 10-year review. Plast Reconstr Surg. 2007;119:915–24.CrossRefPubMedGoogle Scholar
  41. 41.
    Kadam D. Limb salvage surgery. Indian J Plast Surg. 2013;46(2):265–74.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Saint-Cyr M, et al. Free tissue transfers and replantation. Plast Reconstruct Surg. 2012;130:858e.CrossRefGoogle Scholar
  43. 43.
    Choudry UH, et al. The vascularized medial femoral condyle periosteal bone flap for the treatment of recalcitrant bony nonunions. Ann Plast Surg. 2008;60(2):174–80.CrossRefPubMedGoogle Scholar
  44. 44.
    BC Cancer Agency. Malignant wound care guidelines. 2001; http://ww.bccancer.bc.ca.
  45. 45.
    Barton P, Parslow N. Caring for oncology wounds- management guidelines. 1998. http://www.worldwidewounds.com.
  46. 46.
    Cartwright A. Nutritional assessment as part of wound management. Nursing Times. 2002;98(44):62–3.PubMedGoogle Scholar
  47. 47.
    Collier M. Management of patients with fungating wounds. Nurs Stand. 2000;15(11):46–52.CrossRefPubMedGoogle Scholar
  48. 48.
    “Care of malignant wounds” BCCA guidelines. 2004. http://www.bccancer.bc.ca/.
  49. 49.
    Seaman S. Dressing selection in chronic wound management. J Am Podiatr Med Assoc. 2002;92:24–33.CrossRefPubMedGoogle Scholar
  50. 50.
    Ford-Dunn S. Use of vacuum assisted closure therapy in the palliation of a malignant wound. Palliat Med. 2006;20(4):477–8.CrossRefPubMedGoogle Scholar
  51. 51.
    Cihoric N, et al. Clinically significant bleeding in incurable cancer patients: effectiveness of hemostatic radiotherapy. Radiat Oncol. 2012;7:132.CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Lund-Nielsen B, et al. Qualitative bacteriology in malignant wounds – a prospective, randomized, clinical study compare the effect of honey and silver dressing. Ostomy Wound Manage. 2011;57:28–36.PubMedGoogle Scholar
  53. 53.
    Seaman S. Management of malignant fungating wounds in advanced cancer. Semin Oncol Nurs. 2006;22:185–93.CrossRefPubMedGoogle Scholar
  54. 54.
    Kerihuel JC. Effect of activated charcoal dressings on healing outcomes of chronic wounds. J Wound Care. 2010;19(208):210–2, 214–5.Google Scholar
  55. 55.
    Ashford RFU, et al. Metronidazole in smelly tumours. Lancet. 1980;1:874–5.CrossRefPubMedGoogle Scholar
  56. 56.
    Patterson DR, et al. Hypnotherapy as a treatment for pain in patients with burns: research and clinical considerations. J Burn Care Rehabil. 1987;8:263–8.CrossRefPubMedGoogle Scholar
  57. 57.
    Greengrass RA, Duclas Jr R. Paravertebral blocks. Int Anesth Clin. 2012;50:56–73.CrossRefGoogle Scholar
  58. 58.
    Krajnik M, et al. Potential uses of topical opioids in palliative care – report of 6 cases. Pain. 1999;80:121–5.CrossRefPubMedGoogle Scholar
  59. 59.
    Flock P. Pilot study to determine the effectiveness of diamorphine gel to control pressure ulcer pain. J Pain Symptom Manage. 2003;25:547–54.CrossRefPubMedGoogle Scholar
  60. 60.
    Vernassier C, et al. Study to determine the efficacy of topical morphine on painful chronic skin ulcers. J Wound Care. 2005;14:289–93.CrossRefGoogle Scholar

Copyright information

© Springer India 2016

Authors and Affiliations

  1. 1.Department of Geriatric, Neurosciensces and OrthopaedicsUniversity Hospital Agostino Gemelli, Catholic University of the Sacred HeartRomeItaly

Personalised recommendations